Larry A. Bradbury

Larry Bradbury is a procurement professional with a specialized focus on life sciences and medical technology acquisitions, driving the agency’s mission to secure critical diagnostic and laboratory equipment. He manages a diverse portfolio of contracts spanning in-vitro diagnostic substance manufacturing, medical laboratory services, and analytical instrument procurement, ensuring compliance with federal acquisition regulations and technical specifications. His role centers on facilitating timely, compliant, and mission-critical acquisitions that support public health infrastructure and scientific research capabilities. Bradbury maintains a broad vendor network, engaging both large-scale manufacturers and specialized small businesses across the medical diagnostics and instrumentation sectors. While no single contractor dominates his award profile, his contracting patterns reflect consistent engagement with firms capable of delivering high-precision laboratory equipment, clinical testing supplies, and analytical instrumentation. He prioritizes vendors with demonstrated technical expertise in regulatory compliance, quality management systems, and FDA-aligned production standards. His set-aside preferences reveal a strong commitment to small business participation, with over 16% of acquisitions reserved for small business categories, including Total Small Business Set-Asides, 8(a) competed contracts, and Service-Disabled Veteran-Owned Small Business Set-Asides. This reflects a deliberate strategy to expand market access for qualified socioeconomically disadvantaged firms while maintaining rigorous performance standards. The majority of his awards remain open competition, indicating a balanced approach between broad market access and targeted socioeconomic goals. Bradbury’s primary industry focus lies in NAICS 325413 (in-vitro diagnostic substances), 621511 (medical laboratories), and 334516 (analytical laboratory instrument manufacturing), underscoring deep expertise in clinical diagnostics, laboratory automation, and precision analytical systems. He routinely procures reagents, test kits, automated analyzers, and calibration standards critical to public health surveillance and research laboratories, demonstrating technical fluency in biopharmaceutical and clinical testing domains.